Sign In
Home
Panzyga
Get your patient on
Panzyga
(Immune Globulin Intravenous (Human))
injectable - 100 mg/ml injection 300 ml
Check coverage
See the specific documentation and step therapies required.
Check coverage
Medication interactions
See all drug-to-drug interactions for this medication.
Check interactions
Prescribing info
PubMedâ„¢ news
Panzyga prescribing information
Data source
Data source
Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as changes are made available
Report Adverse Event
Check medication interactions
Review interactions as part of your prescribing workflow
Check interactions
Panzyga PubMedâ„¢ news
Last year
Publication date
Article Type
Format
5 articles
Reset Filters
5 most recent articles for Panzyga
,
view all articles on PubMedâ„¢
Journal Article • 2026 May
Vasculitis-associated aberrant apolipoprotein A2 = VAP2 and SDF-1α in Kawasaki disease patients with coronary artery lesion.
Journal Article • 2026 May
Development of an Improved QCM-D Instrumentation for Affinity Sensing by Bioinspired Molecular-Imprinted Polymers (MIP) for IgG Detection in Serum.
Journal Article • 2026 May
A validated ligand binding assay for the determination of etalanetug, a novel anti-tau therapeutic antibody, in rats and monkeys for nonclinical pharmacokinetic studies.
Journal Article • 2026 May
Cooperative protein-ligand antioxidant activation: Sulforaphane binding to human serum immunoglobulin Genhances neuroprotection in spinal cord neurons via structural and functional modifications.
Journal Article • 2026 Apr
Sensitive Colorimetric Biosensors Based on Perovskite Heterojunction Phototransistors.
Show the latest PubMedâ„¢ articles for Panzyga
I certify that I'm a U.S. healthcare provider